Rivaroxaban - a newly marketed antithrombotic agent

Abstract

Anticoagulants, factor Xa inhibitors - rivaroxaban, prophylaxis of thromboembolic events

Keywords

• Anticoagulants
• factor Xa inhibitors
• rivaroxaban
• prophylaxis of thromboembolic events